Project/Area Number |
17590228
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
General pharmacology
|
Research Institution | Teikyo University |
Principal Investigator |
NAKAKI Toshio Teikyo Univ., Pharmacology, Professor, 医学部, 教授 (30164148)
|
Co-Investigator(Kenkyū-buntansha) |
MATSUMURA Nobuko Teikyo Univ., Pharmacology, Researcher, 医学部, 助手 (30317698)
UTSUMI Kazue Teikyo Univ., Pharmacology, Researcher, 医学部, 助手 (90271759)
|
Project Period (FY) |
2005 – 2006
|
Project Status |
Completed (Fiscal Year 2006)
|
Budget Amount *help |
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2006: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 2005: ¥2,200,000 (Direct Cost: ¥2,200,000)
|
Keywords | methamphetamine / prazosin / alpha-1 adrenoceptors / alpha-1b adrenoceptor / neurodegeneration / Parkinson's disease / 神経変性 / 実験室温度調節 / α1B受容体 |
Research Abstract |
A nonselective alpha-1 adrenoceptor antagonist prazosin protected methamphetamine-induced neuronal toxicity, while a selective alpha-lb adrenoceptor antagonist failed to do so. We conclude that the neuro-protective effect of prazosin is some unidentified mechanisms other than the alpha-lb receptor blockade.
|